DEF: Synopsys Transforms with Ansys Acquisition, Reports Record Revenue
Proxy Statement
Synopsys reports record fiscal 2025 revenue of $7.054 billion, driven by the strategic acquisition of Ansys, positioning the company as a leader in engineering solutions from silicon to systems.
Summary
- Synopsys completed the acquisition of Ansys in July 2025, transforming its position from an EDA leader to an engineering solutions leader across silicon to systems.
- Fiscal 2025 saw record revenue of $7.054 billion, an increase of approximately 15% year-over-year.
- GAAP operating margin was 13.0%, while non-GAAP operating margin reached 37.3%.
- Operating cash flow was approximately $1.52 billion, with free cash flow at approximately $1.35 billion.
- The company reported a backlog of $11.4 billion, with approximately 45% of the non-cancellable FSA portion expected to be recognized as revenue over the next 12 months.
- Product innovations in 2025 included partnerships for angstrom era semiconductor manufacturing, expanded hardware-assisted verification for AI chip design, GenAI capabilities to accelerate design workflows, and integration of NVIDIA Omniverse technology into simulation and analysis products.
- The Board nominated ten directors for election at the 2026 Annual Meeting, reducing the board size from twelve members.
- The company is seeking stockholder approval for an Amended and Restated Equity Incentive Plan to include non-employee directors and streamline equity compensation administration.
- Executive compensation for fiscal 2025 was largely performance-based, with the Executive Incentive Plan (EIP) achieving 81.95% of target payouts due to strong non-GAAP operating margin and revenue backlog performance.
- The Fiscal 2023 Annual PRSUs resulted in a 0% payout factor due to a 10.3% CAGR Revenue Growth against a 13.0% target and an rTSR at the 38th percentile.
- The company changed its fiscal year end to October 31, beginning with fiscal 2025.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this filing positively due to record revenue, strong non-GAAP operating performance, and the strategic Ansys acquisition, which positions Synopsys for future growth. While the 0% payout on 2023 PRSUs highlights challenging targets, the overall financial health and strategic direction are strong.
Positives
- Record revenue of $7.054 billion in fiscal 2025, up approximately 15% year-over-year, demonstrating strong business growth.
- Achieved a robust non-GAAP operating margin of 37.3%, indicating efficient operations and profitability.
- Generated significant operating cash flow of approximately $1.52 billion and free cash flow of approximately $1.35 billion.
- Secured a substantial backlog of $11.4 billion, providing future revenue visibility.
- Successfully completed the acquisition of Ansys in July 2025, broadening market reach into automotive, aerospace, robotics, industrial, and healthcare sectors.
- Demonstrated strong product innovation with GenAI capabilities, AgentEngineer technology for chip design, and NVIDIA Omniverse integration for physical AI development.
- Maintained a strong commitment to corporate governance with 80% independent directors and fully independent committees.
- Executive compensation program is heavily weighted towards performance-based and at-risk pay, aligning management interests with stockholders.
Negatives
- Experienced impact from export restrictions and execution challenges related to the evolving IP landscape in the Design IP business.
- The Fiscal 2023 Annual PRSUs resulted in a 0% payout due to not meeting the 13.0% CAGR revenue growth target (achieved 10.3%) and underperforming on rTSR (38th percentile vs. 50th percentile target).
- GAAP operating margin was significantly lower at 13.0% compared to the non-GAAP operating margin of 37.3%, indicating substantial non-GAAP adjustments.
Risks
- Impact of export restrictions and execution challenges related to the evolving IP landscape.
- Risks associated with integrating acquired companies, specifically the Ansys acquisition, and realizing expected synergies.
- Challenges in managing engineering complexity and the demand for compute performance driven by artificial intelligence.
- Potential for macroeconomic or broader industry conditions to deteriorate, impacting revenue backlog targets.
- Risks related to information technology security, cybersecurity, and data security, which are actively overseen by the Governance Committee.
- Risks related to AI usage, requiring responsible and effective deployment, overseen by the Synopsys AI Tools Review Board.
- The acceleration of an equity award in the event of an acquisition or similar corporate event may be viewed as an anti-takeover provision, which may have the effect of discouraging a proposal to acquire or otherwise obtain control of Synopsys.
Future Outlook
Synopsys expects to further its technology leadership in early 2026 with the delivery of integrated capabilities fusing multiphysics from Ansys across Synopsys' full EDA stack, including multi-die advanced packaging. The company is continuing its transformation with a focus on technology leadership, operational excellence, and financial discipline, aiming to redefine how products are imagined and built. The company will discontinue the use of stock options for NEOs in fiscal 2026, shifting to RSUs and PRSUs with relative TSR as a core performance metric, and increasing the performance-based component for the CEO's annual equity package to 60%.
Management Comments
- "As the engineering solutions leader from silicon to systems Synopsys is uniquely positioned to deliver unprecedented value to our customers across industries."
- "Fiscal 2025 was a year that redefined Synopsys and our role in product engineering. The completion of the acquisition of simulation and analysis leader Ansys in July 2025 transformed Synopsys overnight from the leader in EDA to the leader in engineering solutions from silicon to systems."
- "Artificial intelligence will revolutionize every industry -demanding more compute performance while compounding engineering complexity. Building complex, AI-powered systems with the right performance, scale, and efficiency requires new tools with multi-domain integration and new workflows to enable tight software and hardware co-design. Engineering needs to be re-engineered."
- "While we felt the impact of export restrictions and execution challenges related to the evolving IP landscape in our business, we believe our long-term strategy is sound and is already producing results for Synopsys, our customers and our stockholders."
- "The best is yet to come, and together, we are poised to shape what's next."
Industry Context
StockSavvy.ai notes that Synopsys' acquisition of Ansys is a significant strategic move, positioning the company to capitalize on the growing demand for integrated engineering solutions driven by AI and increasing complexity in chip and system design. This expansion beyond traditional EDA into broader multiphysics simulation aligns with a trend of convergence in the technology sector, where companies seek to offer more comprehensive solutions across the design and development lifecycle. The focus on AI-driven design workflows and digital twins reflects the industry's push for efficiency and innovation in the face of advanced manufacturing challenges like the angstrom era. The company's move to discontinue stock options for NEOs in favor of RSUs and PRSUs with relative TSR metrics also reflects an industry trend towards compensation structures that more directly align executive incentives with long-term shareholder value and market performance.
Comparison to Industry Standards
- Synopsys' non-GAAP operating margin of 37.3% for fiscal 2025 is strong, indicating efficient operations within the software and semiconductor industries, which often see high margins for intellectual property and specialized software.
- The 15% year-over-year revenue growth is competitive, especially considering the scale of $7.054 billion, and is likely bolstered by the Ansys acquisition, which expands its market footprint beyond core EDA.
- The shift in executive equity compensation from stock options to RSUs and PRSUs with relative TSR metrics aligns with best practices seen in leading technology companies like Adobe Inc., Oracle Corporation, and KLA Corporation, which prioritize long-term shareholder alignment and retention while managing dilution.
- The 0% payout for the Fiscal 2023 Annual PRSUs, due to missing both revenue CAGR and rTSR targets, demonstrates that the company's performance metrics are rigorous and not easily achieved, reflecting a commitment to 'pay for performance' that is often sought by institutional investors when compared to peers.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President and Chief Executive Officer | Dr. Aart J. de Geus (Co-CEO) | Sassine Ghazi | 2024-01-01 | Dr. de Geus stepped down as CEO, transitioning to Executive Chair. |
| Executive Chair of the Board of Directors | N/A | Dr. Aart J. de Geus | 2024-01-01 | Transition from CEO role to support leadership transition and leverage institutional knowledge. |
| General Counsel and Corporate Secretary | John F. Runkel, Jr. | Janet Lee | 2025-07 | Succession planning in connection with the Ansys acquisition; Ms. Lee previously served as Ansys Senior Vice President, General Counsel and Secretary. |
| Chief Legal Officer (Advisory Role) | N/A | John F. Runkel, Jr. | 2025-07 | Transition role to ensure successful handover and support 2025 fiscal year closing, position subsequently eliminated in January 2026. |
| Chief Revenue Officer | Rick Mahoney | N/A | 2025-11 | Mr. Mahoney ceased serving in this role, transitioned to Executive Advisor, position subsequently eliminated in February 2026. |
| Executive Advisor | N/A | Rick Mahoney | 2025-11 | Transition role to support 2025 fiscal year closing and customer/partner relationships, position subsequently eliminated in February 2026. |
| Director | Luis Borgen | N/A | 2026-04-16 | Not renominated for election to the Board; term expires at the conclusion of the Annual Meeting. |
| Director | Dr. Ajei Gopal | N/A | 2026-04-16 | Not renominated for election to the Board; term expires at the conclusion of the Annual Meeting. |
| Director | N/A | Peter A. Shimer | 2026-02 | Appointed to the Board as part of ongoing evaluation and refreshment, bringing substantial leadership experience. |
| Director | N/A | Ravi Vijayaraghavan | 2025-07 | Appointed to the Board in accordance with the Ansys Merger Agreement. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition | The Board will reduce its size from twelve to ten members following the 2026 Annual Meeting, as Luis Borgen and Dr. Ajei Gopal were not renominated. | 2026-04-16 | Aims to maintain a balance between fresh viewpoints and institutional knowledge, and to ensure effective oversight, with a continued focus on diversity of skills and experience. |
| Equity Incentive Plan | Proposed Amended and Restated Equity Incentive Plan to include non-employee directors, eliminating the need for a separate 2017 Non-Employee Directors Equity Incentive Plan. It also removes certain limitations no longer required by Section 162(m) of the Code, approves an overall limit on director compensation, includes a venue requirement for litigation, and updates delegation authority. | 2026-04-16 (if approved by stockholders) | Reduces administrative burden, aligns with current market practice for equity compensation, and incorporates corporate governance best practices such as stockholder approval for additional shares, no discounted options, and limitations on non-employee director compensation. |
| Executive Compensation Policy | Approved a shift of RSU vesting schedules for all employees from four years to three years with semi-annual vesting, and discontinued the use of stock options for NEOs, replacing them with RSUs and PRSUs where relative TSR is a core performance metric. | Fiscal 2026 compensation planning cycle | Harmonizes equity compensation practices across the combined Synopsys-Ansys organization, enhances retention during integration, and reinforces long-term alignment of executive compensation with stockholder value creation relative to peers. |
| Fiscal Year End | Changed the fiscal year end to October 31, beginning with fiscal 2025. Previously, it ended on the Saturday closest to October 31. | Fiscal 2025 | Simplifies financial reporting and aligns with a fixed calendar date. |
Related Party Transactions
- Synopsys entered into a Termination Notice and Separation Agreement and General Release dated July 17, 2025, with Dr. Ajei Gopal, a current director. Pursuant to this agreement, Dr. Gopal received certain compensation and benefits, including cash severance payments and full vesting of restricted stock unit awards granted by Ansys (valued at approximately $74.28 million on the vesting date), in connection with his termination of employment by Synopsys in July 2025. These benefits were in accordance with his employment agreement with Ansys.
Stakeholder Impact
- **Shareholders:** The record revenue, strategic acquisition, and strong backlog indicate potential for continued long-term value creation. The proposed changes to the Equity Incentive Plan and executive compensation aim to align management and director interests with shareholder value. The reduction in board size and ongoing refreshment efforts are intended to improve independent oversight.
- **Employees:** The Ansys acquisition expands career opportunities and the shift to three-year RSU vesting with semi-annual vesting is intended to enhance retention and harmonize compensation practices across the combined organization. The company's AI Academy provides training resources for employees.
- **Customers:** Product innovations like GenAI capabilities, AgentEngineer technology, and NVIDIA Omniverse integration aim to accelerate design workflows and create enhanced digital twins, delivering unprecedented value and helping customers build complex, AI-powered systems more efficiently.
- **Management:** Executive compensation is tied to challenging performance goals, incentivizing strong financial results and strategic execution. The transition of key executive roles and board refreshment ensures leadership continuity and fresh perspectives.
Next Steps
- Hold the 2026 Annual Meeting of Stockholders on April 16, 2026, to vote on director elections, the Amended and Restated Equity Incentive Plan, executive compensation, auditor ratification, and a stockholder proposal.
- Deliver the first set of integrated capabilities fusing multiphysics from Ansys across Synopsys' full EDA stack, including multi-die advanced packaging, in early 2026.
- Continue the ongoing transformation with a focus on technology leadership, operational excellence, and financial discipline.
- Discontinue the use of stock options for NEOs and shift to RSUs and PRSUs with relative TSR as a core performance metric, effective fiscal 2026.
- Publish the final voting results of the Annual Meeting in a Current Report on Form 8-K within four business days after April 16, 2026.
- Furnish the 2025 Responsible Business Report later in 2026.
Key Dates
| Date | Description |
|---|---|
| 1986 | Dr. Aart J. de Geus co-founded Synopsys. |
| 1999 | Dr. de Geus established the Synopsys Foundation. |
| 2001 | Bruce R. Chizen joined the Board of Directors. |
| 2006-04-25 | Original effective date of the Equity Incentive Plan, approved by stockholders. |
| 2007 | John G. Schwarz joined the Board of Directors. |
| 2014 | Janice D. Chaffin joined the Board of Directors. |
| 2017 | Mercedes Johnson joined the Board of Directors. |
| 2020 | Jeannine P. Sargent joined the Board of Directors. |
| 2023 | Sassine Ghazi and Robert G. Painter joined the Board of Directors. |
| 2023-08 | Dr. de Geus announced decision to step down as CEO effective January 1, 2024. |
| 2023-12 | Share ownership guidelines for directors were most recently amended. |
| 2024-01-01 | Sassine Ghazi became President and Chief Executive Officer; Dr. Aart J. de Geus transitioned to Executive Chair. |
| 2024-02-13 | Schedule 13G/A filed by The Vanguard Group, Inc. reporting beneficial ownership as of December 29, 2023. |
| 2024-01-15 | Agreement and Plan of Merger with Ansys and ALTA Acquisition Corp. dated. |
| 2024-01-26 | Schedule 13G/A filed by BlackRock, Inc. reporting beneficial ownership as of December 31, 2023. |
| 2024-03 | Splunk Inc. was acquired, leading to its removal from the fiscal 2025 peer group. |
| 2024-04 | John G. Schwarz began serving as Lead Independent Director. |
| 2024-10-31 | Fiscal year end for 2025 (new fiscal year end). |
| 2024-11-02 | Fiscal year end for 2024 (previous fiscal year end). |
| 2024-12-18 | Grant date for annual stock options and RSUs for fiscal 2025 NEOs. |
| 2024-12 | Additional shares granted for overachievement of target performance for 2025 PRSUs. |
| 2025-01-14 | Grant date for annual performance-based restricted stock units (PRSUs) for fiscal 2025 NEOs. |
| 2025-02 | Peter A. Shimer was appointed to Synopsys' Board. |
| 2025-07 | Completion of the acquisition of Ansys; Dr. Ajei Gopal and Ravi Vijayaraghavan appointed to the Board. |
| 2025-07-17 | Termination Notice and Separation Agreement and General Release with Dr. Ajei Gopal dated. |
| 2025-07 | John F. Runkel, Jr. was succeeded by Janet Lee as General Counsel and Corporate Secretary. |
| 2025-09-11 | Grant date for Janet Lee's new hire RSU grant. |
| 2025-10-31 | Last day of fiscal 2025. |
| 2025-11 | Mr. Mahoney ceased serving as Chief Revenue Officer. |
| 2025-12-16 | Compensation Committee certification date for Fiscal 2023 Annual PRSUs. |
| 2025-12-22 | 2025 Annual Report on Form 10-K filed with the SEC. |
| 2026-02-02 | Board of Directors adopted the Amended and Restated Equity Incentive Plan. |
| 2026-02-17 | Record Date for the 2026 Annual Meeting of Stockholders. |
| 2026-02-19 | Proxy Statement and 2025 Annual Report on Form 10-K made available to stockholders. |
| 2026-04-15 | Deadline for voting by Internet or telephone for the Annual Meeting. |
| 2026-04-16 | Date of the 2026 Annual Meeting of Stockholders. |
| 2026-09-22 | Earliest date for stockholder proposals for the 2027 Annual Meeting under advance notice provisions. |
| 2026-10-22 | Latest date for stockholder proposals for the 2027 Annual Meeting under advance notice provisions and universal proxy rules. |
| 2026-12-02 | Full vesting date for Shelagh Glaser's 2022 option grant. |
| 2026-12-08 | First annual installment vesting date for Shelagh Glaser's 2024 RSU grant. |
| 2027-02-17 | Full vesting date for Sassine Ghazi's, Dr. Aart J. de Geus', Shelagh Glaser's, and Rick Mahoney's 2023 option grants. |
| 2027-03-01 | Full vesting date for Janet Lee's 2025 Ansys assumed RSU grant. |
| 2027-12-12 | Full vesting date for Sassine Ghazi's, Dr. Aart J. de Geus', Shelagh Glaser's, and Rick Mahoney's 2023 option grants. |
| 2028-02-16 | Full vesting date for Janet Lee's 2025 Ansys assumed RSU grant. |
| 2028-12-09 | Full vesting date for Sassine Ghazi's and Dr. Aart J. de Geus' 2021 option grants. |
| 2028-12-18 | Full vesting date for Sassine Ghazi's, Dr. Aart J. de Geus', Shelagh Glaser's, and Rick Mahoney's 2024 option grants. |
| 2036-02-02 | No Incentive Stock Options may be granted on or after this date under the Amended and Restated Equity Incentive Plan. |
Recommendation
buySynopsys demonstrates strong financial performance with record revenue and robust non-GAAP operating margins, indicating effective business operations. The strategic acquisition of Ansys significantly expands its market reach and capabilities in critical growth areas like AI and multiphysics simulation, positioning the company for sustained long-term growth. While the 0% payout on the 2023 PRSUs highlights rigorous performance targets, the overall trajectory and strategic initiatives, coupled with a strong backlog and commitment to innovation, suggest a positive outlook. The company's proactive approach to corporate governance and executive compensation alignment further supports a 'buy' recommendation for long-term investors.
Keywords
Synopsys, Ansys, SEC Filing, Proxy Statement, Financial Results, Revenue, Operating Margin, Cash Flow, Backlog, Acquisition, EDA, Engineering Solutions, Semiconductor, AI, Artificial Intelligence, Corporate Governance, Executive Compensation, Equity Incentive Plan, Risk Management, Cybersecurity, Shareholder Meeting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.